INVIVO AND INVITRO FATE OF FENVALERATE IN HOUSE-FLIES
INVIVO AND INVITRO FATE OF FENVALERATE IN HOUSE-FLIES
复制标题
DOI:
10.1016/0048-3575(90)90047-6
复制
发表时间:
1990-10-01
影响因子:
4.7
通讯作者:
PRYOR, NW
中科院分区:
文献类型:
--
作者:
BULL, DL;PRYOR, NW
Investigations of pyrethroid resistant (R) and susceptible (S) house flies (Musca domestica L.) provided conclusive evidence that a high level of cross-resistance to fenvalerate in the laboratory-selected R strain was influenced by an enhanced capability for metabolic degradation of the toxicant. Comparative studies of the in vitro metabolism of [14C]fenvalerate by homogenate preparations of S and R house flies, in the presence or absence of the mixed function oxidase (mfo) inhibitor piperonyl butoxide (PBO) or the esterase inhibior S,S,S-tributylphosphorothioate (DEF), indicated that elevation of mfo activity was a major component of enhanced metabolism and that there also was enhancement of esterase associated with both the microsomal and cytosolic subcellular fractions of homogenate preparations of R insects. In vivo studies of the effects of coadministered PBO or DEF on the absorption and metabolism of topically applied [14C]fenvalerate in R insects demonstrated that both synergists slowed the rate at which the toxicant penetrated the cuticle; PBO significantly reduced the metabolic degradation of fenvalerate, but effects of DEF on metabolism were less conclusive.